Pain therapeutics--SMi's seventh annual conference. 12-13 June 2006, London, UK.
Harrop
Sarah
S
Thomson Scientific, Middlesex House, 34-42 Cleveland Street, London, W1T 4JE, UK. sarah.harrop@thomson.com
D000700:Analgesics / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D002986:Clinical Trials as Topic; D016207:Cytokines / Q000037:antagonists & inhibitors; D006801:Humans; D020932:Nerve Growth Factor / Q000037:antagonists & inhibitors; D010146:Pain / Q000188:drug therapy* / Q000503:physiopathology; D043885:Receptor, Cannabinoid, CB2 / Q000037:antagonists & inhibitors; D026941:Sodium Channel Blockers / Q000494:pharmacology; D050916:TRPV Cation Channels / Q000037:antagonists & inhibitors
D000700:Analgesics; D016207:Cytokines; D043885:Receptor, Cannabinoid, CB2; D026941:Sodium Channel Blockers; D050916:TRPV Cation Channels; C494482:TRPV1 protein, human; D020932:Nerve Growth Factor